Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival

Recent studies suggest that inflammation response biomarkers are prognostic indicators of solid tumor outcomes. Here, we quantify the prognostic value of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in glioblastomas (GBMs), taki...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng-Fei, Song, Hong-Wang, Cai, Hong-Qing, Kong, Ling-Wei, Yao, Kun, Jiang, Tao, Li, Shou-Wei, Yan, Chang-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564834/
https://www.ncbi.nlm.nih.gov/pubmed/28223536
http://dx.doi.org/10.18632/oncotarget.15235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564834/
https://www.ncbi.nlm.nih.gov/pubmed/28223536
http://dx.doi.org/10.18632/oncotarget.15235

Ejemplares similares